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Development of a Patient-Centric Food Allergy Research Program: A Model for Action 
 
To the Editor: 
Attention to patient perspectives on healthcare and disease burden is the guiding principle 
of patient-centered outcomes research (1) and is an approach increasingly employed by 
researchers in allergic disease settings, such as asthma (2) and allergic rhinosinusitis (3) and 
urticaria (4).  Because of the all-encompassing impact of food allergies on daily living, including 
social and economic effects, the food allergy context is especially suited for an approach to 
research designed to account for the lived experiences of food allergic patients and their families. 
  Despite recent advances in understanding the effects of food allergy on quality of life, 
gaps still exist in key areas like participation in clinical trials, access to safe foods and 
epinephrine and public understanding of food allergies (4 5). Outcomes research offers the 
opportunity to examine the lives of those impacted by food allergies to determine the wide range 
of issues that are most important to those directly affected and to address these gaps (5 6). The 
goal of this letter is to describe a model for engaging key stakeholders in the development of a 
patient-centric food allergy research agenda. 
To address gaps in patient-centered food allergy outcomes research, Food Allergy 
Research & Education (FARE) successfully competed for a Eugene Washington Engagement 
Award from the Patient-Centered Outcomes Research Institute (PCORI), and in May 2016, 
announced a two-year initiative entitled “Empowering Patient Partners and Key Stakeholders to 
Develop a Patient-Centric Food Allergy Research Program.” FARE created an Outcomes 
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Research Advisory Board (ORAB) as a key component of this initiative to create a stakeholder-
driven, outcomes-centered research agenda. A call for applications to the ORAB was announced 
in the FARE newsletter and via the FARE web site, and members were selected through a 
conflict-free vetting process.  
The ORAB is comprised of individuals with an array of experiences, including 
individuals with food allergies; parents of children with food allergies, academic, community-
based, and industry researchers; and other stakeholders such as nurses, educators, advocates, 
health plan payers and pharmacy benefit managers. Select clinicians and researchers from the 
FARE Clinical Network also serve on the board. The 44 members are organized into four 
regional subgroups (Midwest, Northeast Mid-Atlantic, South and West), with each subgroup 
comprised of 10-12 members. The board was charged with working collectively to identify and 
prioritize a set of food allergy research initiatives informed by patient needs and experiences. 
The ORAB began working in the summer of 2016 when each of the regional groups met 
in person (see Figure 1). Over the next seven months, the regional groups continued meeting 
online and via conference call, and communicating via email to narrow and define research 
priorities. The meetings allowed the board to stay-up-to-date on emerging findings regarding 
new discoveries about possible causes of food allergy, potential therapeutic developments, and 
FARE’s work in education, awareness and advocacy. Each subgroup conducted an online survey 
of its members to prioritize a list of the most pressing patient-centered topic areas requiring 
greater attention from the research community. 
In March of 2017, each regional subgroup drafted a white paper outlining the five to six 
priority areas identified in its online survey. For each topic area, subgroups identified the existing 
knowledge in that area (e.g. current science on the efficacy of oral immunotherapy); specific 
3 
unanswered questions that influence the experiences of food allergic patients and families (e.g. 
the preponderance of false positives in the diagnostic process); gaps in adherence or data relating 
to the topic (e.g. evidence suggesting that many patients do not know how to correctly administer 
an epinephrine autoinjector); ideas for including patient input in future study designs; and 
suggestions for addressing underserved populations to reduce disparities in care. The four 
completed papers were then distributed to the entire national board and submitted to PCORI as 
part of FARE’s first-year progress report. 
In April 2017, the ORAB members met at FARE’s Annual Research Retreat. Members 
engaged in day-long focus groups to prepare a national agenda of research priorities. The groups 
compared the four white papers and narrowed the list of priorities to five categories: therapeutic 
developments, diagnostic processes, improved product labeling, enhanced forms of epinephrine 
and quality of life issues involved in living with food allergies (see Table 1). Working in small 
groups organized by topic, the ORAB developed a short presentation for each topic area. During 
the second day of the Research Retreat, representatives from the ORAB presented these topic 
areas to an audience of FARE-funded and other leading scientists, as well as senior 
representatives from the National Institutes of Health, the Food and Drug Administration, and 
the pharmaceutical industry. In doing so, the ORAB highlighted the voices of adult allergy 
patients and caregivers of food-allergic children in describing the most pressing needs of the 
food allergy community. In addition, ORAB members, in conjunction with board advisers, 
conducted a pre and post survey before and after the research retreat to measure whether 
attendees’ ratings of research priorities changed after hearing ORAB members present. These 
survey results have been submitted for presentation at an academic conference, and a full-length 
manuscript reporting the results is currently in draft. 
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The ORAB serves as an exemplary model for involving key constituents in the 
development of a long-term research agenda.  To date, the ORAB’s research agenda has been 
presented at meetings of the American College of Asthma, Allergy and Immunology (ACAAI), 
the Patient Organization Committee of the European Academy of Allergy and Clinical 
Immunology (EAACI) and the first food allergy meeting hosted by the prestigious Gordon 
Research Conference. The work will be presented at additional conferences in the coming 
months.  
We urge scientists and funding agencies committed to improving the lives of food allergy 
patients to account for the priorities identified by the ORAB in formulating research questions 
and making funding decisions. As emerging immunotherapies become more widely available, 
we must continue to draw on patient voices to understand patient and family perspectives on 
adherence to such therapies and the effects these therapies might have on the social and 
economic effects of food allergy (4 5). 
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